Hemofarm - News - STADA Health Report: Ageing anxiety - 43% of Europeans fear getting older

Age is just a number – but is it really? The STADA Health Report 2024 shows that 43 percent of Europeans are afraid of ageing. The fear is even more pronounced among younger adults, with 46 percent of individuals aged 18 to 34 expressing concerns about getting older. The STADA Health Report also highlights a significant gender disparity in ageing anxiety. Women in general are more apprehensive about ageing than men. This trend is most evident among young women, with nearly one in two aged 18 to 34 fearing the prospect of growing older (49).

Among all respondents who are afraid of ageing, their main concern is physical decline (68). 60 percent are afraid of getting an age-related illness such as Parkinsons, Alzheimer’s or Dementia. Almost as many (59) are afraid of becoming a burden to others in old age.

These are the results of the sixth international STADA Health Report 2024, a representative study with over 46,000 respondents from 23 countries. On behalf of STADA Arzneimittel AG, the market research institute Human8 surveyed around 2,000 people each between the ages of 18 and 99 from: Austria, Belgium, Bulgaria, the Czech Republic, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Kazakhstan, the Netherlands, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland, the United Kingdom and Uzbekistan. Further information on the STADA Health Report and much more can be found at: STADA Health Report 2024 (stada-healthreport-2024.com).

About STADA Arzneimittel AG
STADA Arzneimittel AG is headquartered in Bad Vilbel, Germany. The company focuses on a three-pillar strategy consisting of generics, specialty pharma and consumer healthcare products. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. In the financial year 2022, STADA achieved group sales of EUR 3,797.2 million and reported earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 884.7 million. As of 31 December 2022, STADA employed 13,183 people worldwide.

Additional information for journalists:
STADA Arzneimittel AG - Media Relations
Stadastrasse 2-18
61118 Bad Vilbel - Germany
Phone: +49 (0) 6101 603-165
Fax: +49 (0) 6101 603-215
E-Mail: press@stada.de
Or visit us on the Internet at www.stada.com/press

Additional information for capital market participants:
STADA Arzneimittel AG - Investor & Creditor Relations
Stadastrasse 2-18
61118 Bad Vilbel – Germany
Phone: +49 (0) 6101 603-4689
Fax: +49 (0) 6101 603-215
E-mail: ir@stada.de
Or visit us on the Internet at www.stada.com/investor-relations